Exane Derivatives’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$122K Hold
1,707
0.07% 245
2022
Q1
$167K Sell
1,707
-209
-11% -$20.5K 0.05% 381
2021
Q4
$162K Hold
1,916
0.04% 371
2021
Q3
$153K Buy
1,916
+498
+35% +$39.7K 0.04% 447
2021
Q2
$143K Buy
+1,418
New +$143K 0.03% 482